We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+5.81%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$3.9B
AUM Growth
+$252M
Cap. Flow
+$73.2M
Cap. Flow %
1.88%
Top 10 Hldgs %
29.07%
Holding
576
New
42
Increased
208
Reduced
140
Closed
20

Top Sells

Rank Stock Value
1
DD icon
DuPont de Nemours
DD
+$8.42M
2
TMO icon
Thermo Fisher Scientific
TMO
+$3.09M
3
AAPL icon
Apple
AAPL
+$2.88M
4
ASML icon
ASML
ASML
+$2.49M
5
TIF
Tiffany & Co.
TIF
+$2.36M

Sector Composition

Rank Sector Weight
1 Technology 19.5%
2 Healthcare 14.83%
3 Financials 12.72%
4 Communication Services 8.9%
5 Consumer Staples 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
V icon
151
Visa
V
$677B
$2.93M 0.08%
13,838
+2,024
+17% +$426K
VIXM icon
152
ProShares VIX Mid-Term Futures ETF
VIXM
$56.8M
$2.9M 0.07%
83,448
+74,890
+875% +$2.94M
YUMC icon
153
Yum China
YUMC
$15.7B
$2.9M 0.07%
48,965
-455
-0.9% -$27.2K
PNC icon
154
PNC Financial Services
PNC
$99.1B
$2.88M 0.07%
16,429
+677
+4% +$112K
TSLA icon
155
Tesla
TSLA
$1.18T
$2.88M 0.07%
12,930
+1,515
+13% +$380K
FITB
156
Fifth Third Bancorp
FITB
$51.3B
$2.85M 0.07%
76,167
-178
-0.2% -$6.04K
IJJ icon
157
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.83B
$2.83M 0.07%
27,778
-254
-0.9% -$24.2K
DVY icon
158
iShares Select Dividend ETF
DVY
$23.8B
$2.8M 0.07%
24,512
+2
+0% +$211
ISRG icon
159
Intuitive Surgical
ISRG
$127B
$2.75M 0.07%
11,157
-285
-2% -$71.7K
CI icon
160
Cigna
CI
$78.4B
$2.7M 0.07%
11,172
-1,800
-14% -$401K
CMI icon
161
Cummins
CMI
$83.6B
$2.67M 0.07%
10,306
-25
-0.2% -$6.25K
ITOT icon
162
iShares Core S&P Total US Stock Market ETF
ITOT
$92.3B
$2.61M 0.07%
28,451
+2,100
+8% +$188K
SYK icon
163
Stryker
SYK
$135B
$2.49M 0.06%
10,231
-10
-0.1% -$2.4K
MSCI icon
164
MSCI
MSCI
$42.4B
$2.37M 0.06%
5,662
-370
-6% -$155K
OXY icon
165
Occidental Petroleum
OXY
$55.7B
$2.33M 0.06%
+87,602
New +$2.19M
MDT icon
166
Medtronic
MDT
$112B
$2.27M 0.06%
19,242
+3,164
+20% +$371K
IWF icon
167
iShares Russell 1000 Growth ETF
IWF
$117B
$2.26M 0.06%
37,228
CVS icon
168
CVS Health
CVS
$135B
$2.25M 0.06%
29,941
+137
+0.5% +$9.98K
NOC icon
169
Northrop Grumman
NOC
$76B
$2.2M 0.06%
6,789
-850
-11% -$256K
EVRG icon
170
Evergy
EVRG
$19.4B
$2.14M 0.05%
35,948
-74
-0.2% -$4.09K
AON icon
171
Aon
AON
$80.6B
$2.12M 0.05%
9,213
SHV icon
172
iShares 0-1 Year Treasury Bond ETF
SHV
$20.8B
$2.01M 0.05%
18,214
+9,384
+106% +$1.04M
BNY
173
Bank of New York Mellon
BNY
$103B
$1.98M 0.05%
41,808
-643
-2% -$28.3K
PHG icon
174
Philips
PHG
$25.5B
$1.97M 0.05%
42,567
-7,184
-14% -$326K
EQR icon
175
Equity Residential
EQR
$25.8B
$1.97M 0.05%
27,441
-2,992
-10% -$198K

Similar funds

Gofen & Glossberg's Q1 2021 Portfolio in Review

As of Q1 2021, Gofen & Glossberg held 576 positions worth $3.9B, up 6.9% from $3.65B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Gofen & Glossberg's Q1 2021 filing shows 42 new, 208 increased, 140 reduced and 20 closed positions. Its largest new stake was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 284,378 shares worth $8.13M. The largest sale was DuPont de Nemours, an estimated $8.42M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.

  • Gofen & Glossberg's largest Q1 2021 buy was Quadratic Interest Rate Volatility and Inflation Hedge ETF: 284,378 shares worth $8.13M.
  • Gofen & Glossberg added most to Air Products & Chemicals in Q1 2021, an estimated $15.8M increase.
  • Gofen & Glossberg's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $8.42M.
  • Gofen & Glossberg fully exited Tiffany & Co. in Q1 2021, selling an estimated $2.36M.
  • Gofen & Glossberg's ten largest holdings make up 29% of its $3.9B portfolio in Q1 2021.
  • Gofen & Glossberg opened 42 new positions and closed 20 in Q1 2021.
  • Gofen & Glossberg's portfolio value rose 6.9% quarter-over-quarter to $3.9B.

Based on Gofen & Glossberg's 13F filing for Q1 2021, filed 13 Apr 2021.